Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -129.67% is 52% below its 5-year average of -85.15%, around the middle of its 5-year range (-248.52%–-30.37%).
As of the fiscal period ended Tuesday, June 30, 2026. 4.88% above its 12-month average of -136.32%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -129.67%.
RETURN ON INVESTED CAPITAL (ROIC)
-129.67%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-136.32%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-97.53%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-85.15%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+4.88%
CURRENT VS 3Y AVG
-32.96%
CURRENT VS 5Y AVG
-52.28%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-263.78%
vs the sector median at left
Fractyl Health, Inc.
Market Cap
$61.87M
Return on Invested Capital (ROIC)
-129.67%
TTM Avg
-136.32%
3Y Avg
-97.53%
5Y Avg
-85.15%
Market Cap
$61.55M
Return on Invested Capital (ROIC)
-52.40%
TTM Avg
-44.92%
3Y Avg
-44.92%
5Y Avg
-44.02%
Market Cap
$60.03M
Return on Invested Capital (ROIC)
-26.13%
TTM Avg
-90.47%
3Y Avg
-104.07%
5Y Avg
-130.48%
Market Cap
$60.21M
Return on Invested Capital (ROIC)
-1235.48%
TTM Avg
-801.38%
3Y Avg
-433.95%
5Y Avg
-312.84%
Market Cap
$59.58M
Return on Invested Capital (ROIC)
-604.20%
TTM Avg
-195.52%
3Y Avg
-273.84%
5Y Avg
-208.65%
Market Cap
$59.41M
Return on Invested Capital (ROIC)
-79.68%
TTM Avg
-67.52%
3Y Avg
-59.81%
5Y Avg
-47.97%
Market Cap
$62.50M
Return on Invested Capital (ROIC)
-6.79%
TTM Avg
-4.87%
3Y Avg
-47.70%
5Y Avg
-62.00%
Market Cap
$63.97M
Return on Invested Capital (ROIC)
-139.74%
TTM Avg
-190.33%
3Y Avg
-1114.56%
5Y Avg
-840.48%
Market Cap
$63.47M
Return on Invested Capital (ROIC)
-56.22%
TTM Avg
-67.31%
3Y Avg
-52.91%
5Y Avg
-45.67%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fractyl Health, Inc. (GUTS) | $61.87M | -129.67% | -136.32% | -97.53% | -85.15% |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.55M | -52.40% | -44.92% | -44.92% | -44.02% |
| Xilio Therapeutics, Inc. (XLO)vs › | $60.03M | -26.13% | -90.47% | -104.07% | -130.48% |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.21M | -1235.48% | -801.38% | -433.95% | -312.84% |
| MiNK Therapeutics, Inc. (INKT)vs › | $59.58M | -604.20% | -195.52% | -273.84% | -208.65% |
| Adicet Bio, Inc. (ACET)vs › | $59.41M | -79.68% | -67.52% | -59.81% | -47.97% |
| Heron Therapeutics, Inc. (HRTX)vs › | $62.50M | -6.79% | -4.87% | -47.70% | -62.00% |
| RenovoRx, Inc. (RNXT)vs › | $63.97M | -139.74% | -190.33% | -1114.56% | -840.48% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.47M | -56.22% | -67.31% | -52.91% | -45.67% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $58.59M | -136.77% | -80.48% | -75.99% | -77.22% |
ROIC
-129.7%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -129.67% |
| 2026-03-31 | -110.60% |
| 2025-12-31 | -89.50% |
| 2025-09-30 | -103.30% |
| 2025-06-30 | -248.52% |
| 2025-03-31 | -139.75% |
| 2024-12-31 | -105.92% |
| 2024-09-30 | -70.01% |
| 2024-06-30 | -54.01% |
| 2024-03-31 | -40.11% |
| 2023-12-31 | -75.03% |
| 2023-09-30 | -101.82% |
| 2023-06-30 | -150.58% |
| 2022-12-31 | -92.06% |
| 2021-12-31 | -39.03% |
| 2021-09-30 | -30.68% |
| 2021-06-30 | -30.37% |
| 2021-03-31 | -29.42% |
| 2020-12-31 | -93.38% |
